LEGN - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Legend Biotech Corporation – LEGN | Benzinga
NEW YORK, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Legend Biotech Corporation ("Legend" or the "Company") (NASDAQ:LEGN). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.
The investigation concerns whether Legend and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On November 28, 2023, the U.S. Food and Drug Administration ("FDA") announced that ...